2008 Barcelona - European Society of Human Genetics

Keyword Index
HYPERPLASTIC POLYPOSIS SYNDROME:
P04.006
hyperplastic polyposis: P04.012
hypertelorism: P03.36
hypertension: P06.134
Hypertriglyceridaemia: P05.115
hypertrophic cardiomyopathy: EPL6.4,
P01.183, P01.299, P01.300, P01.301,
P05.090, P05.092
hyperuricaemia: P06.168
hyperuricemia: P01.059, P05.093
hypochondroplasia: P01.132
hypogenitalism: P01.317
hypogonadism: C01.6, P01.366
hypomelanosis: P01.308
Hypomethylation: P02.055
hypomyelination: P05.199
hypoplastic left heart: P01.243, P01.342
hypospadia: P02.101
hypospadias: P01.363
Hypothalamic dysfunction: P01.302
Hypotonia: P02.203
hypoventilation: P01.302
hypoxanthine-guanine
phosphoribosyltransferase: P05.093
IBD: P06.135, P07.022
ICF syndrome: P05.094
ICSI: P01.272, P01.303
IDE: P06.016
identical twins: P01.290
idic(Y): P03.45
idiopathic bronchiectasis: P06.136
Idiopathic Epilepsy: P05.095
Idiopathic Mental Retardation: P02.027
Idiopathic short stature: P05.180
idiopathic ventricular arrhythmias: P05.096
IGF-1: P07.004
IGF1R gene: P02.172
IGR2096a_1: P06.071
IGR2230a_1: P06.068
Ikaros: C10.5
IL-10: P05.142
IL12B: P06.028, P06.189
IL18RAP: P06.045, P06.070
IL1B: P06.223
IL1R1: P06.218
IL1RAPL1,PAK3: P06.315
IL1RL2: P06.218
IL23R: P06.069, P06.267
IL2RA: P06.190
IL2RG: P06.265
IL4: P06.027, P07.011, P07.047
IL4R: P06.124
IL4RA: P07.047
IL-6: P04.175, P06.015
IL6: P06.223
IL7Rα: P06.191
illness risk representations: EPL1.5
Illumina: P02.034, P06.085
Imatinib mesylate: P04.102
imatinib resistance: P04.091
immune cells: P05.140
immune defense modifier genes: P06.036
Immunodeficiency: P06.120
immunogenetics: P06.086
immunologic impairment: P01.355
immunoresponse genes: P06.215
immunotherapy: P05.194
Impaired spermatogenesis: P05.097
impaired transactivation: P05.052
imprinting centers: P05.098
improvement: P09.20
in situ: C05.6
in utero: S10.1
INAD: P05.099
inbreeding: P06.132, P07.071
incidence in Slovakia: P06.187
increased bone density: C03.3
IND B: P06.130
indels: C05.2
Indigenous: P07.072
Indirect genetic diagnosis: P06.228
individual susceptibility: P07.012
Infantile neuroaxonal dystrophy: P05.099
infantile-onset spasticity: P05.100
infertile men: P02.223
infertility: P02.220, P02.226, P02.230,
P02.232, P07.073, P09.40
inflammation: P05.137
inflammatory bowel disease: P05.101,
P06.137, P06.138
Inflammatory bowel diseases: P06.139
Information and support needs: EP13.8
information booklet: P09.54
Information resource: P09.48
information: EP10.17, EP13.1
informative: P05.144
informed choice: EPL4.1, P03.46
informing relatives: EPL1.2
inheritance: P09.04
Inherited Heart Disorders: P08.79
inherited metabolic disorders: P05.216
Inherited rearrangements: P02.020
inhibitors: P06.123
INPP1: P02.040
INS: P05.102
Ins96: P07.035
INSIG2: P06.099
insurance: EPL5.1
Integrated Platform: P08.70
integrated screening: P03.02
Intention-behavior gap: EP06.3
Interactome: P05.204
Interleukin1α and B: P07.097
interleukin-6: P06.172
interleukine-4: P05.104
internal standard: P08.66
international networking: P09.31
international: P09.05
interpopulation crosses: P06.132
interpreters: EP10.18
Interruption: P05.174
interspersed repeats: P08.43
interstitial deletion 11q: P01.304
interstitial deletion: P02.111, P02.133
Intrachromosomal insertion: P02.152
intrachromosomal rearrangement: P02.198
Intractable epilepsy: P02.081
intron-1 inversion: P05.078
inv dup 15: P02.153
invasion: P04.015, P04.206
inversion: P02.154, P02.155
inversions: P02.156
inverted duplication: P01.305
ionizing radiation: EP01.11
IRAK-M: P06.140
Iran: P01.009, P01.018, P01.023, P05.081,
P06.088, P06.192, P06.305, P07.005,
P07.063
iranian population: P01.024, P06.269,
P07.074
IRF5: C08.1
IRF6: P06.217
iron: P07.067
irritable bowel syndrome: C08.2
IRS1 polymorphisms: P06.141
IRS-2: P06.142
ischaemic vascular disease: P06.002
ischemia: P05.105, P05.106
ischemic stroke: P06.023, P06.143
ISH: P01.306
isodicentric X chromosomes: P02.157
isodisomy: P01.307
isoform: P04.134
isolate: P07.068
isolated population: P06.153
isolated populations: P07.077
Italy: EP14.11
Ito: P01.308
ITPA gene: P04.093
ıvf: P02.167
IVS3+G476A: P06.023
IVS8-5T allele: P02.237
IVSInt-130: P01.009
Jacobsen syndrome: P02.012
JAK2 gene V617F: P04.118
Jak2 V617F mutation: P04.083
JAK2 V617F: P04.111
Japan: EP01.01
Japanese: P06.229
JME: P05.107
JMML: P01.193
Joubert Syndrome: P01.309, P06.144, S13.2
JPS: P04.007
jumping translocation: P02.158
juvenile idiopathic arthritis: P06.039
juvenile stroke syndrome: P05.126
K channelopathies: P05.108
K562 cells: P10.17
Kalirin: P06.276
kardiogenetic: P09.39
karyotype: P02.045, P02.181, P02.199,
P04.077, P04.130, P09.40
karyotyping: P02.151, P02.193, P02.195,
P03.47, P04.050, P04.115
Kazakh population: P06.046
KCNE1: P05.109, P06.210
KCNH2: P05.108, P05.166
KCNJ10 gene: P06.145